Mankind Pharma shares extend gains over the last month after Jefferies raises target

Starting FY27, Mankind Pharma should achieve 1.5 times the growth seen in the Indian Pharmaceutical Market (IPM) and show further improvement in margins, Jefferies added.

Leave a Reply

Your email address will not be published. Required fields are marked *